WuXi PharmaTech (NYSE: WX) Endows a New Faculty Position at Tongji University

    SHANGHAI, China, April 16 /Xinhua-PRNewswire/ -- WuXi PharmaTech
 (Cayman) Inc. (NYSE:   WX), a leading pharmaceutical, biotechnology and
 medical device research and development outsourcing company with operations
 in China and the United States, today announced it endowed a new professor
 position in the Medical and Life Science School of Tongji University.
 
     (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )
 
     Dr. Gang Pei, President of Tongji University, Dr. Jian Fei, Deputy Dean
 of the Medical and Life Science School of Tongji University, Dr. Ge Li,
 Chairman and CEO of WuXi PharmaTech and other company representatives
 attended the endowment ceremony on April 9, 2008. The endowed professor
 position will be filled by people selected from accomplished scholars and
 professors in medical, pharmaceutical and biological fields around the
 world.
 
     Tongji University ( http://www.tongji.edu.cn/english/inc/index.asp ),
 whose history can be traced back to 1907 when Tongji German Medical School
 was founded by Erich Paulun, a German doctor in Shanghai, is one of the
 leading universities in China. The name Tongji suggests cooperating by
 riding the same boat.
 
     Commenting on WuXi PharmaTech's endowment, Dr. Pei said, ''WuXi
 PharmaTech, one of the most successful enterprises, has made
 widely-recognized achievements and showcased strong pharmaceutical R&D
 power in China. WuXi's generosity not only helps our research and teaching
 activities, but also creates a new industry-academia collaboration model
 that will attract more talents and make a positive impact on the domestic
 pharmaceutical industry.''
 
     ''We are very happy and honored to establish such a professor position
 for Tongji University. As a global leading pharmaceutical, biotechnology
 and medical device R&D outsourcing company, WuXi strives to be a good
 corporate citizen. Through the endowment WuXi and Tongji University
 together are charting a course for stimulating and promoting China's
 pharmaceutical R&D,'' commented Dr. Ge Li, Chairman and CEO of WuXi
 PharmaTech.
 
     About WuXi PharmaTech
 
     WuXi PharmaTech, headquartered in Shanghai, China, is the leading
 global pharmaceutical, biotechnology and medical device R&D outsourcing
 company. As a research-driven and customer-focused company, WuXi PharmaTech
 provides pharmaceutical, biotechnology and medical device companies a broad
 and integrated portfolio of laboratory, research manufacturing, biologics
 testing and manufacturing services throughout the drug and medical device
 research and development process. WuXi PharmaTech's services are designed
 to assist its global partners in shortening the cycle and lowering the cost
 of drug and medical device research and development by providing
 cost-effective and efficient outsourcing solutions that save its customers
 both time and money. For more information, please visit:
 http://www.wuxipharmatech.com .
 
 
For more information, please contact: Sherry Shao Tel: +86-21-5046-4002 Email: pr@pharmatechs.com

SOURCE WuXi PharmaTech

More by this Source

Best of Content We Love 2014 


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.